BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37628806)

  • 1. Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic Cardiomyopathy.
    Laird J; Perera G; Batorsky R; Wang H; Arkun K; Chin MT
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Cui H; Schaff HV; Lentz Carvalho J; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Lee AT; Bos JM; Ackerman MJ; Ommen SR; Maleszewski JJ
    J Am Coll Cardiol; 2021 May; 77(17):2159-2170. PubMed ID: 33926651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
    Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
    Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.
    Varnava AM; Elliott PM; Baboonian C; Davison F; Davies MJ; McKenna WJ
    Circulation; 2001 Sep; 104(12):1380-4. PubMed ID: 11560853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.
    Vakrou S; Liu Y; Zhu L; Greenland GV; Simsek B; Hebl VB; Guan Y; Woldemichael K; Talbot CC; Aon MA; Fukunaga R; Abraham MR
    Sci Rep; 2021 Jun; 11(1):13163. PubMed ID: 34162896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy.
    Liu Y; Afzal J; Vakrou S; Greenland GV; Talbot CC; Hebl VB; Guan Y; Karmali R; Tardiff JC; Leinwand LA; Olgin JE; Das S; Fukunaga R; Abraham MR
    Front Cardiovasc Med; 2019; 6():170. PubMed ID: 31921893
    [No Abstract]   [Full Text] [Related]  

  • 7. Common and Distinctive Intercellular Communication Patterns in Human Obstructive and Nonobstructive Hypertrophic Cardiomyopathy.
    Codden CJ; Chin MT
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-computed tomography (micro-CT) for the assessment of myocardial disarray, fibrosis and ventricular mass in a feline model of hypertrophic cardiomyopathy.
    Novo Matos J; Garcia-Canadilla P; Simcock IC; Hutchinson JC; Dobromylskyj M; Guy A; Arthurs OJ; Cook AC; Luis Fuentes V
    Sci Rep; 2020 Nov; 10(1):20169. PubMed ID: 33214588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy.
    Wehrens M; de Leeuw AE; Wright-Clark M; Eding JEC; Boogerd CJ; Molenaar B; van der Kraak PH; Kuster DWD; van der Velden J; Michels M; Vink A; van Rooij E
    Cell Rep; 2022 May; 39(6):110809. PubMed ID: 35545053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.
    Teekakirikul P; Zhu W; Huang HC; Fung E
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31888115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and Genetic Profiles of Cases with Myocytes Disarray-Investigation for Establishing the Autopsy Diagnostic Criteria for Hypertrophic Cardiomyopathy.
    Hata Y; Ichimata S; Yamaguchi Y; Hirono K; Oku Y; Ichida F; Nishida N
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy.
    Garmany R; Bos JM; Tester DJ; Giudicessi JR; Dos Remedios CG; Dasari S; Nagaraj NK; Nair AA; Johnson KL; Ryan ZC; Maleszewski JJ; Ommen SR; Dearani JA; Ackerman MJ
    Circ Genom Precis Med; 2023 Apr; 16(2):e003756. PubMed ID: 36802768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics.
    Liu X; Yin K; Chen L; Chen W; Li W; Zhang T; Sun Y; Yuan M; Wang H; Song Y; Wang S; Hu S; Zhou Z
    Cell Discov; 2023 Jan; 9(1):6. PubMed ID: 36646705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
    Marian AJ; Braunwald E
    Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death.
    Finocchiaro G; Sheikh N; Leone O; Westaby J; Mazzarotto F; Pantazis A; Ferrantini C; Sacconi L; Papadakis M; Sharma S; Sheppard MN; Olivotto I
    Europace; 2021 Jul; 23(7):985-995. PubMed ID: 33447843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction.
    Chou C; Chin MT
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
    Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
    Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy.
    Rixon C; Andreassen K; Shen X; Erusappan PM; Almaas VM; Palmero S; Dahl CP; Ueland T; Sjaastad I; Louch WE; Stokke MK; Tønnessen T; Christensen G; Lunde IG
    ESC Heart Fail; 2023 Apr; 10(2):858-871. PubMed ID: 36444917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
    Marian AJ
    Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.